PubMed laboratory research record [PMID: 36755926] PubMed record related to this compound for laboratory literature review
Sources: Teichman et al., JCEM 2006 | Raun et al., Eur J Endocrinol 1998 | Alba et al., Am J Physiol 2006 Security Profile & Chemical Identity Molecular specifications of the two peptides and documented hormonal selectivity Chemical Identity Pre-formulated Mix Two complementary peptides targeting distinct receptors for synergistic GH stimulation Documented Hormonal Selectivity Profile verified in human clinical trials Key benefit of this combination Published Clinical Data Key studies on each component and the synergy of GHRH + GHRP 2-10x Dose-dependent increase in plasma GH (30-60 g/kg SC) Results CJC-1295 (days 28 and 49) Selective First GH secretagogue without raising cortisol, prolactin or ACTH levels Selectivity vs
GSNO is metabolized by the NADH-dependent GSNOR, which thereby shifts the cellular equilibrium to disfavor protein SNOs, while Trxs and TrxRs denitrosylate proteins directly
Think twice before injecting peptides bought online: unauthorized products can seriously harm you
AHK-Cu has also been studied for its potential involvement in anti-inflammatory signaling and angiogenesis modulation
For guidance on the regulation of research compounds in the UK, see the MHRA.